Integrum AB Series B (INTEG-B) - Total Liabilities

Latest as of March 2026: Skr31.59 Million SEK ≈ $3.40 Million USD

Based on the latest financial reports, Integrum AB Series B (INTEG-B) has total liabilities worth Skr31.59 Million SEK (≈ $3.40 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Integrum AB Series B - Total Liabilities Trend (2013–2025)

This chart illustrates how Integrum AB Series B's total liabilities have evolved over time, based on quarterly financial data. See INTEG-B working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Integrum AB Series B Competitors by Total Liabilities

The table below lists competitors of Integrum AB Series B ranked by their total liabilities.

Company	Country	Total Liabilities
Andromeda Metals Ltd AU:ADN	Australia	AU$2.27 Million
GWR Group Ltd AU:GWR	Australia	AU$7.38 Million
Fiplasto SA BA:FIPL	Argentina	AR$62.74 Billion
Pulsenmore Ltd TA:PULS	Israel	ILA45.83 Million
Indofarma Tbk JK:INAF	Indonesia	Rp1.47 Trillion
Mistral Iberia Real Estate SOCIMI S.A. MC:YMIB	Spain	€11.51 Million
Kintech Electronics Co Ltd TWO:6210	Taiwan	NT$114.82 Million
Puloon Technology Inc KQ:094940	Korea	₩7.37 Billion

Liability Composition Analysis (2013–2025)

This chart breaks down Integrum AB Series B's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Integrum AB Series B (INTEG-B) market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.77	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.18	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.16	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Integrum AB Series B's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Integrum AB Series B (2013–2025)

The table below shows the annual total liabilities of Integrum AB Series B from 2013 to 2025.

Year	Total Liabilities	Change
2025-12-31	Skr31.59 Million ≈ $3.40 Million	+24.48%
2024-12-31	Skr25.38 Million ≈ $2.73 Million	+14.98%
2023-12-31	Skr22.07 Million ≈ $2.38 Million	+2.01%
2022-12-31	Skr21.64 Million ≈ $2.33 Million	+4.55%
2021-12-31	Skr20.70 Million ≈ $2.23 Million	+60.25%
2020-12-31	Skr12.91 Million ≈ $1.39 Million	+52.49%
2019-12-31	Skr8.47 Million ≈ $911.38K	-4.33%
2018-12-31	Skr8.85 Million ≈ $952.60K	+5.65%
2017-12-31	Skr8.38 Million ≈ $901.62K	-9.31%
2016-12-31	Skr9.24 Million ≈ $994.23K	+2.27%
2015-12-31	Skr9.03 Million ≈ $972.20K	+71.03%
2014-12-31	Skr5.28 Million ≈ $568.43K	-5.99%
2013-12-31	Skr5.62 Million ≈ $604.66K	--

About Integrum AB Series B

ST:INTEG-B Sweden Medical Devices

Market Cap

$22.88 Million

Skr212.65 Million SEK

Market Cap Rank

#24689 Global

#489 in Sweden

Share Price

Skr8.17

Change (1 day)

-0.24%

52-Week Range

Skr6.96 - Skr43.10

All Time High

Skr102.00